AGEs Cancer Research Results

AGEs, Advanced Glycation End Products: Click to Expand ⟱
Source:
Type:
Advanced Glycation End Products (AGEs) are highly reactive compounds formed when proteins or lipids become non-enzymatically glycated after exposure to sugars. AGEs accumulate with age and are implicated in various chronic diseases—including Alzheimer’s disease (AD).
-AGEs bind to Aβ peptides, increasing aggregation and plaque stability.
-AGEs activate kinases like GSK-3β and p38 MAPK, promoting tau phosphorylation.
-Human brains with AD show increased AGE-modified proteins and elevated RAGE expression.
-Blocking RAGE or reducing AGEs slows cognitive decline and pathology in mice.

Strategies to Reduce AGE Burden
-Low-AGE cooking (steaming, boiling), Mediterranean diet
- reduce processed meats, sugary baked goods, and fried foods.




Diabetic, Diabetic: Click to Expand ⟱
Diabetic


Scientific Papers found: Click to Expand⟱
6281- DL,    Applications of Limonene in Neoplasms and Non-Neoplastic Diseases
- Review, Var, NA - Review, AD, NA - Review, Diabetic, NA
*antiOx↑, AntiTum↑, *AntiDiabetic↑, *neuroP↑, *GastroP↑, *ROS↓, *toxicity↓, *BioAv↑, ChemoSen↑, BAX↑, P53↓, Bcl-2↓, iNOS↓, COX2↓, eff↑, ROS↑, TumCCA↑, cycD1/CCND1↓, CycB/CCNB1↓, TumCMig↓, *lipid-P↓, *GSH↑, *SOD↑, *GPx↑, *hepatoP↑, *glucose↓, *AGEs↓, *Obesity↓, *Aβ↓, *AChE↓,
4529- MAG,    Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
- Review, Diabetic, NA
*AntiDiabetic↑, *glucose↓, *SOD↑, *Catalase↑, *ROS↓, *MDA↓, *GPx↑, *CYP2E1↓, *AGEs↓, *IL10↑, *neuroP↑, *GutMicro↑,
5795- MET,    Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
- Review, AD, NA - Review, Park, NA - Review, Diabetic, NA
*AntiDiabetic↑, *AMPK↑, *glyC↓, *ROS↓, *cardioP↑, *neuroP↑, *Half-Life↝, *toxicity↝, *BioAv↑, *glucose↓, *AGEs↓, AntiCan↑, Risk↓, TumCP↓, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, pRB↓, p27↓, mTOR↓, Casp↑, ROS↑, MMP↓, ChemoSen↑, *hepatoP↑, *CRM↑, *Insulin↓,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

ROS↑, 2,  

Mitochondria & Bioenergetics

MMP↓, 1,  

Cell Death

Apoptosis↑, 1,   BAX↑, 1,   Bcl-2↓, 1,   Casp↑, 1,   iNOS↓, 1,   p27↓, 1,  

Transcription & Epigenetics

pRB↓, 1,  

DNA Damage & Repair

P53↓, 1,  

Cell Cycle & Senescence

CycB/CCNB1↓, 1,   cycD1/CCND1↓, 2,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State

mTOR↓, 1,  

Migration

TumCMig↓, 1,   TumCP↓, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,  

Drug Metabolism & Resistance

ChemoSen↑, 2,   eff↑, 1,  

Functional Outcomes

AntiCan↑, 1,   AntiTum↑, 1,   Risk↓, 1,  
Total Targets: 22

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 1,   Catalase↑, 1,   CYP2E1↓, 1,   GPx↑, 2,   GSH↑, 1,   lipid-P↓, 1,   MDA↓, 1,   ROS↓, 3,   SOD↑, 2,  

Mitochondria & Bioenergetics

Insulin↓, 1,  

Core Metabolism/Glycolysis

AMPK↑, 1,   CRM↑, 1,   glucose↓, 3,   glyC↓, 1,  

Barriers & Transport

GastroP↑, 1,  

Immune & Inflammatory Signaling

IL10↑, 1,  

Synaptic & Neurotransmission

AChE↓, 1,  

Protein Aggregation

AGEs↓, 3,   Aβ↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 2,   Half-Life↝, 1,  

Clinical Biomarkers

GutMicro↑, 1,  

Functional Outcomes

AntiDiabetic↑, 3,   cardioP↑, 1,   hepatoP↑, 2,   neuroP↑, 3,   Obesity↓, 1,   toxicity↓, 1,   toxicity↝, 1,  
Total Targets: 29

Scientific Paper Hit Count for: AGEs, Advanced Glycation End Products
1 D-limonene
1 Magnolol
1 Metformin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:61  Cells:%  prod#:%  Target#:1375  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page